A study to Evaluate AB308 in Combination with AB122 in Participants with Advanced Malignancies (ARC-12)

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511116-25-00

Acronym

ARC-12

Enrollment

Registered

2024-05-10

Start date

2022-12-13

Completion date

2025-08-25

Last updated

2025-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumor, Cervical Cancer, Diffuse large B cell lymphoma (DLBCL), Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastrointestinal (GI) cancer, Gynecological (Gyn) cancer, Hematological (heme) cancer, Melanoma, Multiple Myeloma, Non-Hodgkin Lymphoma, Non-small cell lung cancer (NSCLC)

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Poland, Spain

Outcome results